Predictive Ability of a Clinical-Genetic Risk Score for Venous Thromboembolism in Northern and Southern European Populations

Abstract

Venous thromboembolism (VTE) is a complex, multifactorial problem, the development of which depends on a combination of genetic and acqfiguired risk factors. In a Spanish population, the Thrombo inCode score (or TiC score), which combines clinical and genetic risk components, was recently proven better at determining the risk of VTE than the commonly used model involving the analysis of two genetic variants associated with thrombophilia: the Factor V Leiden (F5 rs6025) and the G20210A prothrombin (F2 rs1799963).

The aim of the present case–control study was to validate the VTE risk predictive capacity of the TiC score in a Northern European population (from Sweden).

The study included 173 subjects with VTE and 196 controls. All were analyzed for the genetic risk variants included in the TiC gene panel. Standard measures —receiver operating characteristic (ROC) area under the curve (AUC), sensitivity, specificity, and odds ratio (OR)—were calculated.

The TiC score returned an AUC value of 0.673, a sensitivity of 72.25%, a specificity of 60.62%, and an OR of 4.11. These AUC, sensitivity, and OR values are all greater than those associated with the currently used combination of genetic variants. A TiC version adjusted for the allelic frequencies of the Swedish population significantly improved its AUC value (0.783).

In summary, the TiC score returned more reliable risk estimates for the studied Northern European population than did the analysis of the Factor V Leiden and the G20210A genetic variations in combination. Thus, the TiC score can be reliably used with European populations, despite differences in allelic frequencies.

Keywords

venous thromboembolism - genetic - risk score - primary prevention - anticoagulation - pulmonary embolism - deep vein thrombosis

Publikationsverlauf

Eingereicht: 09. September 2020

Angenommen: 01. März 2021

Artikel online veröffentlicht:
08. Juli 2021

• References

• 1 Cohen AT, Agnelli G, Anderson FA. et al; VTE Impact Assessment Group in Europe (VITAE). Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007; 98 (04) 756-764
• 2 Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism. J Thromb Thrombolysis 2016; 41 (01) 3-14
• 3 Northup A, Wilcox S. Thromboprophylaxis failure in the adult medical inpatient. Am J Med Sci 2017; 354 (02) 107-116
• 4 Galanaud JP, Monreal M, Kahn SR. Epidemiology of the post-thrombotic syndrome. Thromb Res 2018; 164: 100-109
• 5 Prandoni P, Kahn SR. Post-thrombotic syndrome: prevalence, prognostication and need for progress. Br J Haematol 2009; 145 (03) 286-295
• 6 Martinez C, Cohen AT, Bamber L, Rietbrock S, Martinez C. Epidemiology of first and recurrent venous thromboembolism: a population-based cohort study in patients without active cancer. Thromb Haemost 2014; 112 (02) 255-263
• 7 Wong P, Baglin T. Epidemiology, risk factors and sequelae of venous thromboembolism. Phlebology 2012; 27 (Suppl. 02) 2-11
• 8 Konstantinides SV, Mccumber M, Ozaki Y. . Wendelboe a, Weitz JI. Thrombosis: A Major Contributor to Global Disease Burden G.E. Raskob, P. Angchaisuksiri, A.N. Blanco, H. Buller, A. Gallus, B.J. Hunt, E.M. Hylek, A. Kakkar, S.V. Konstantinides, M. McCumber, Y. Ozaki, A. Wendelboe and J.I. Weitz Arterioscler Thromb Vasc. 2014. 34. 2363-2371
• 9 Rubio-Terrés C, Soria JM, Morange PE. et al. Economic analysis of Thrombo inCode, a clinical-genetic function for assessing the risk of venous thromboembolism. Appl Health Econ Health Policy 2015; 13 (02) 233-242
• 10 Dobesh PP. Economic burden of venous thromboembolism in hospitalized patients. Pharmacotherapy 2009; 29 (08) 943-953
• 11 Souto JC, Almasy L, Borrell M. et al. Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia. Am J Hum Genet 2000; 67 (06) 1452-1459
• 12 Soria JM, Morange P-E, Vila J. et al. Multilocus genetic risk scores for venous thromboembolism risk assessment. J Am Heart Assoc 2014; 3 (05) e001060
• 13 Clark JSC, Adler G, Salkic NN, Ciechanowicz A. Allele frequency distribution of 1691G >A F5 (which confers Factor V Leiden) across Europe, including Slavic populations. J Appl Genet 2013; 54 (04) 441-446
• 14 Crous-Bou M, Harrington LB, Kabrhel C. Environmental and genetic risk factors associated with venous thromboembolism. Semin Thromb Hemost 2016; 42 (08) 808-820
• 15 Hanley JA, Hajian-Tilaki KO. Sampling variability of nonparametric estimates of the areas under receiver operating characteristic curves: an update. Acad Radiol 1997; 4 (01) 49-58
• 16 Attia J. Moving beyond sensitivity and specificity: using likelihood ratios to. Aust Prescr 2003; 26: 111-113
• 17 de Haan HG, Bezemer ID, Doggen CJM. et al. Multiple SNP testing improves risk prediction of first venous thrombosis. Blood 2012; 120 (03) 656-663
• 18 Bruzelius M, Bottai M, Sabater-Lleal M. et al. Predicting venous thrombosis in women using a combination of genetic markers and clinical risk factors. J Thromb Haemost 2015; 13 (02) 219-227
• 19 Muñoz Martín AJ, Ortega I, Font C. et al. Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer. Br J Cancer 2018; 118 (08) 1056-1061
• 20 Antonio J, Llamas P, Bellver J. et al. Prediction of recurrent pregnancy loss by a new thrombophilia based genetic risk score. IJSBAR 2018; 42: 61-73
• 21 Baena-Díez JM, Grau M, Sánchez-Pérez R, Altes-Vaques E, Salas-Gaetjens LH, Hernández-Ibáñez MR. The REGICOR-calibrated function provides a better classification of high-risk patients on statin treatment in the Spanish population than the Framingham or SCORE classifications. Rev Esp Cardiol 2009; 62 (10) 1134-1140
• 22 Hua X, McDermott R, Lung T. et al. Validation and recalibration of the Framingham cardiovascular disease risk models in an Australian Indigenous cohort. Eur J Prev Cardiol 2017; 24 (15) 1660-1669
• 23 Iribarren C, Lu M, Jorgenson E. et al. Weighted multi-marker genetic risk scores for incident coronary heart disease among individuals of African, Catino and East-Asian Ancestry. Sci Rep 2018; 8 (01) 6853-6865
• 24 Wassel CL, Rasmussen-Torvik L, Callas PW. et al. A genetic risk score comprising known venous thromboembolism loci is associated with chronic venous disease in a multi-ethnic cohort. Thromb Res 2015; 136: 966-973